查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1133518

全球電刺激器市場-2022-2029

Global Electric Stimulation Devices Market - 2022-2029
出版日期: | 出版商: DataM Intelligence | 英文 180 Pages | 商品交期: 約2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

市場動態

脊髓損傷電刺激的創新有望推動市場增長。

功能性電刺激 (FES) 是一種 NMES，它向癱瘓的神經細胞和肌肉提供電刺激，以刺激肌肉活動以執行功能性任務。 FES 廣泛用於脊髓損傷 (SCI) 後的康復，主要用於恢復肢體功能。 FES 提高了強度生產和抵抗力。 FES 有助於脊髓損傷後上肢功能的恢復。 FES 還用於下肢康復，以增強步行特性，例如腳拉加速度、擺動力和地面衝擊力，從而加快步行速度和更有效的步行肌肉系統。因此，當前醫療保健服務的發展正在刺激對門診提供 FES 策略的研究。

一種解決方案是來自 Myant（加拿大多倫多）的服裝刺激技術。這種服裝將布料與銀線或導電層結合在一起，並在服裝中嵌入電極以提供電刺激。與其他解決方案相比，這些可穿戴服裝應該是可調節的、具有成本效益的、多功能的、耐用的，並且能夠由患者獨立應用。因此，從上述陳述來看，預計市場將在預測期內受到驅動。

與物理治療相關的高成本和嚴格的設備許可阻礙了市場增長。

物理治療的高成本限制了設備的可接受性。冗長的審批流程會導致新產品的上市延遲。嚴格的設備許可規定和電刺激系統替代品的廣泛選擇是預計在預測期內阻礙市場的因素。

COVID-19 影響分析

COVID-19 大流行是人類在上個世紀面臨的最具破壞性的健康危機。缺乏可行的藥物選擇正在阻礙與這種疾病的鬥爭。基於可靠的發現，電刺激可能是目前可用的對症和抗病毒藥物的可行輔助手段。在臨床前研究中，電刺激已被證明可有效改善呼吸功能、抑制 SARS-CoV-2 的生長、緩解疼痛、增強免疫力和提高抗病毒藥物的滲透性。而且，NMES是一種簡單、無創的肌肉強化治療，一般耐受性好，無副作用，需要很少或不需要患者乾預，而且相對便宜，它有一個特點。因此，NMES 療法對 COVID-19 患者身體和肌肉功能的療效可以系統地納入重症監護後綜合徵患者的 ICU 後康復方案中。

全球電子刺激器市場報告提供大約 45 多個市場數據表、40 多個數字和 180 頁結構。

內容

第一章研究方法與範圍

  • 調查方法
  • 調查目的和範圍

第 2 章市場定義和概述

第 3 章執行摘要

第 4 章市場動態

  • 市場影響因子
    • 驅動程序
      • 癱瘓患者神經刺激器的創新有望推動市場增長。
    • 約束因素
      • 預計嚴格的設備許可規定會阻礙市場增長。
    • 機會
    • 影響分析

第五章行業分析

  • 波特的五種力量
  • 未滿足的需求
  • 供應鏈
  • 定價分析
  • 監管分析

第 6 章 COVID-19 分析

  • COVID-19 的市場分析
    • COVID-19 之前的市場情景
    • COVID-19 的當前市場情景
    • COVID-19 後或未來情景
  • COVID-19 期間的價格動態
  • 供需範圍
  • 大流行期間與市場相關的政府舉措
  • 製造商的戰略舉措
  • 總結

第 7 章按設備類型

  • 脊髓刺激器
  • 深部腦刺激器
  • 迷走神經刺激器
  • □神經刺激器
  • 胃刺激器
  • 經皮神經電刺激器
  • 神經肌肉電刺激器
  • 顱內電刺激器
  • 其他

第 8 章. 按應用程序

  • 疼痛管理
  • 神經系統和運動系統疾病的治療
  • 肌肉骨骼疾病管理
  • 新陳代謝和消化系統管理
  • 失禁管理
  • 其他

第 9 章，最終用戶

  • 醫院
  • 專科診所
  • 神經外科中心
  • 門診手術中心
  • 其他

第 10 章按地區劃分

  • 北美
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 意大利
    • 西班牙
    • 其他歐洲
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他南美洲
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 澳大利亞
    • 其他亞太地區
  • 中東和非洲

第 11 章競爭格局

  • 競爭場景
  • 市場情況/份額分析
  • 併購分析

第 12 章公司簡介

  • Boston Scientific Corporation
    • 公司概況
    • 產品組合和描述
    • 主要亮點
    • 財務摘要
  • Cyberonics, Inc
  • Colfax Corporation（DJO Global, Inc.）
  • Medtronic plc
  • Nevro Corporation
  • Abbott
  • NeuroMetrix, Inc.
  • BTL Industries, Inc.
  • Cogentix Medical Inc.
  • Zynex Inc.

第13章 全球電刺激設備市場-DataM

簡介目錄
Product Code: DMMD1062

Market Overview

Electric Stimulation Devices Market size was valued US$ YY million in 2021 and is estimated to reach US$ YY million by 2029, growing at a CAGR of 9.42% during the forecast period (2022-2029).

Electrical stimulators are small electronic devices that patients wear and attach to their skin via electrodes. Electrical stimulators are used for a variety of purposes, including the reduction of acute post-operative pain and swelling, the treatment of chronic intractable pain, the maintenance of muscle tone during temporary extremity immobilization, the reduction of spasticity, and the assistance of spinal cord injured patients to grasp, stand, and walk independently. e stimulation device's lead wires and electrodes are attached to the skin over the target area of the body. Electrical stimulators are also utilized at home by patients.

Market Dynamics

Innovations in electrical stimulation for spinal cord injuries are expected to drive market growtth.

Functional electrical stimulation (FES) is a form of NMES that involves administering electrical stimuli to paralyzed neurons or muscles to stimulate muscular activity to fulfill a functional task. FES is used extensively in rehabilitation following a spinal cord injury (SCI), mostly to regain extremities function. FES has boosted muscle power production and resistance. FES aids in the recovery of upper extremity function following SCI. FES has also been utilized in lower extremity rehabilitation to increase gait characteristics such as foot-pulling acceleration, swing power, and ground impact force, resulting in faster walking speeds and a more efficient system of muscle strength for gait. Therefore, current developments in healthcare delivery have stimulated research into strategies to deliver FES on an outpatient basis.

One solution is Myant's garment-based stimulation technology (Toronto, Canada). These garments combine cloth with silver thread or conductive layers to implant electrodes into the clothing to deliver electrical stimulation. Compared to other solutions, these wearable garments should be adjustable, cost-effective, multifunctional, and durable and allow for independent application by the patient. Thus, from the above statements, the market is expected to drive in the forecast period.

High costs and stringent device licensingare associated with physiotherapy treatments will hamper the market growth

High costs are associated with physiotherapy treatments, resulting in limited device acceptability. Long approval processes are causing delays in introducing new items to the market. Stringent device licensing regulations and a wide choice of electrical stimulation system alternatives are the factors the market is expected to get hampered in the forecast period.

COVID-19 Impact Analysis

The COVID-19 pandemic is the most devastating health crisis that humanity has faced in the last century. The lack of viable medicinal options has hampered the fight against the disease. Based on solid research findings, electric stimulation can be a viable adjuvant to currently utilized symptomatic therapy and antiviral medications. Based on preclinical studies, electric stimulation can improve respiratory functions, limit SARS-CoV-2 growth, alleviate pain, raise immunity, and improve antiviral medication penetration. Furthermore, NMES is a simple and non-invasive therapy for muscle strengthening that is generally well tolerated, produces no adverse effects, requires no or little assistance from patients, and is relatively inexpensive. As a result, demonstrating the efficacy of NMES therapy for physical and muscle function in COVID-19 patients may support its systematic inclusion in post-ICU rehabilitation protocols for patients with post-intensive care syndrome.

Segment Analysis

Pain Management segment is expected to hold the largest market share in electric stimulation devices market.

The pain management segment accounted for the largest market share in 2021. The segment benefits from the increasing prevalence of chronic pain disorders, and the growing usage of Pain Management products due to their high therapeutic advantages are the factors the market is driven in the forecast period. For instance, chronic pain is estimated to affect 11% to 40% of persons in the United States. The most prevalent chronic pain issue is low back pain. Women and people over the age of 65 are more prone to experience chronic pain. Chronic pain costs the United States up to $635 billion every year. Severe depression affects more than 8 out of 10 chronic pain patients. One in every four patients suffering from chronic pain has a sleep disturbance. Chronic pain affects at least 10% of the world's population. Therefore, the demand for electric stimulation devices for chronic pain has increased. Thus, from the above statements, the market segment accounted for the largest market share in the forecast period.

Geographical Analysis

North America region holds the largest market share in the global electric stimulation devices market

North America accounted for the largest market share in 2021. The rise in chronic pain, the prevalence of sports injuries, the rise in the geriatric population, and significant market competitors focused on obtaining FDA approval for novel products to treat patients are the factors the market is driven in the forecast period. For instance, in May 20, 2022, NeuroMetrix, Inc. announced that its wearable technology for chronic pain therapy had gained 510(k) approval (K140333) from the United States Food and Drug Administration (FDA) for over-the-counter usage. The company is nearing the end of developing a consumer-oriented chronic pain management product. The gadget is built on wearable technology, currently used in the Company's SENSUS Pain Management System, to induce safe and effective pain treatment by gentle, non-invasive electrical stimulation of sensory neurons. It is lightweight and can be worn throughout the day and while sleeping. Thus, for the statements, North America accounted for the largest market share in the forecast period.

Competitive Landscape

Major key players in the electric stimulation devices market are Boston Scientific Corporation, Cyberonics, Inc, Colfax Corporation (DJO Global, Inc.), Medtronic plc, Nevro Corporation, Abbott, NeuroMetrix, Inc., BTL Industries, Inc., Cogentix Medical Inc., Zynex Inc.

Boston Scientific Corporation:

Overview:

Boston Scientific Corporation is a developer, manufacturer and marketer of medical devices used in various interventional medical specialties. The company offers its products in businesses such as Interventional Cardiology, Peripheral Interventions, Cardiac Rhythm Management, Electrophysiology, Endoscopy, Urology and Pelvic Health, Neuromodulation and Specialty Pharmaceuticals. Moreover, it operates in three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. MedSurg consists of Endoscopy, Urology, and Pelvic Health businesses. The rhythm segment consists of Cardiac Rhythm Management, Electrophysiology and Neuromodulation businesses. Across 100+ countries, the company delivers care more effectively by reducing costs, increasing efficiencies, and expanding access to care to help more people live healthier lives.

Product Portfolio:

Precision Novi Primary Cell Spinal Cord Stimulator System: Precision Novi is the smallest, thinnest high, capacity primary cell spinal cord stimulator implant with a unique contoured shape. This improved implant shape was designed to enhance patient comfort and address the primary cause of revision surgeries: pain over the implant site.

The global electric stimulation devices market report would provide an access to an approx. 45+market data table, 40+figures and 180pages.

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Market Definition and Overview

3. Executive Summary

4. Market Dynamics

  • 4.1. Market Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Innovations in the nerve-stimulation device for paralyzed patients are expected to drive market growth.
    • 4.1.2. Restraints:
      • 4.1.2.1. Stringent device licensing regulations are expected to hamper market growth.
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Forces
  • 5.2. Unmet Needs
  • 5.3. Supply Chain
  • 5.4. Pricing Analysis
  • 5.5. Regulatory Analysis

6. COVID-19 Analysis

  • 6.1. Analysis of Covid-19 on the Market
    • 6.1.1. Before COVID-19 Market Scenario
    • 6.1.2. Present COVID-19 Market Scenario
    • 6.1.3. After COVID-19 or Future Scenario
  • 6.2. Pricing Dynamics Amid Covid-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During Pandemic
  • 6.5. Manufacturers Strategic Initiatives
  • 6.6. Conclusion

7. By Device Type

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Device Type
    • 7.1.2. Market Attractiveness Index, By Device Type
  • 7.2. Spinal Cord Stimulation Devices*
      • 7.2.1.1. Introduction
      • 7.2.1.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 7.3. Deep Brain Stimulation Devices
  • 7.4. Vagus Nerve Stimulation Devices
  • 7.5. Sacral Nerve Stimulation Devices
  • 7.6. Gastric Electric Stimulation Devices
  • 7.7. Transcutaneous Electrical Nerve Stimulation Devices
  • 7.8. Neuromuscular Electrical Stimulation Devices
  • 7.9. Cranial Electrical Stimulation Devices
  • 7.10. Others

8. By Application

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 8.1.2. Market Attractiveness Index, By Application
  • 8.2. Pain Management*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 8.3. Neurological and Movement Disorder Management
  • 8.4. Musculoskeletal Disorder Management
  • 8.5. Metabolism & GIT Management
  • 8.6. Incontinence Management
  • 8.7. Others

9. By End user

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
    • 9.1.2. Market Attractiveness Index, By End user
  • 9.2. Hospitals*
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 9.3. Specialty Clinics
  • 9.4. Neurosurgical Centers
  • 9.5. Ambulatory Surgical Centers
  • 9.6. Others

10. By Region

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029, By Region
    • 10.1.2. Market Attractiveness Index, By Region
  • 10.2. North America
    • 10.2.1. Introduction
    • 10.2.2. Key Region-Specific Dynamics
    • 10.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Device Type
    • 10.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 10.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
    • 10.2.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.2.6.1. U.S.
      • 10.2.6.2. Canada
      • 10.2.6.3. Mexico
  • 10.3. Europe
    • 10.3.1. Introduction
    • 10.3.2. Key Region-Specific Dynamics
    • 10.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Device Type
    • 10.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 10.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
    • 10.3.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.3.6.1. Germany
      • 10.3.6.2. U.K.
      • 10.3.6.3. France
      • 10.3.6.4. Italy
      • 10.3.6.5. Spain
      • 10.3.6.6. Rest of Europe
  • 10.4. South America
    • 10.4.1. Introduction
    • 10.4.2. Key Region-Specific Dynamics
    • 10.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Device Type
    • 10.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 10.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
    • 10.4.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.4.6.1. Brazil
      • 10.4.6.2. Argentina
      • 10.4.6.3. Rest of South America
  • 10.5. Asia Pacific
    • 10.5.1. Introduction
    • 10.5.2. Key Region-Specific Dynamics
    • 10.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Device Type
    • 10.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 10.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
    • 10.5.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.5.6.1. China
      • 10.5.6.2. India
      • 10.5.6.3. Japan
      • 10.5.6.4. Australia
      • 10.5.6.5. Rest of Asia Pacific
  • 10.6. Middle East and Africa
    • 10.6.1. Introduction
    • 10.6.2. Key Region-Specific Dynamics
    • 10.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Device Type
    • 10.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 10.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user

11. Competitive Landscape

  • 11.1. Competitive Scenario
  • 11.2. Market Positioning/Share Analysis
  • 11.3. Mergers and Acquisitions Analysis

12. Company Profiles

  • 12.1. Boston Scientific Corporation*
    • 12.1.1. Company Overview
    • 12.1.2. Product Portfolio and Description
    • 12.1.3. Key Highlights
    • 12.1.4. Financial Overview
  • 12.2. Cyberonics, Inc
  • 12.3. Colfax Corporation (DJO Global, Inc.)
  • 12.4. Medtronic plc
  • 12.5. Nevro Corporation
  • 12.6. Abbott
  • 12.7. NeuroMetrix, Inc.
  • 12.8. BTL Industries, Inc.
  • 12.9. Cogentix Medical Inc.
  • 12.10. Zynex Inc.

LIST NOT EXHAUSTIVE

13. Global Electric Stimulation Devices Market - DataM

  • 13.1. Appendix
  • 13.2. About Us and Applications
  • 13.3. Contact Us